|
2021 Journal Article Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell TherapyIoannides, Zara A., Csurhes, Peter A., Douglas, Nanette L., Mackenroth, Gem, Swayne, Andrew, Thompson, Kate M., Hopkins, Tracey J., Green, Kerryn A., Blum, Stefan, Hooper, Kaye D., Wyssusek, Kerstin H., Coulthard, Alan and Pender, Michael P. (2021). Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy. Frontiers in Neurology, 12 652811, 652811. doi: 10.3389/fneur.2021.652811 |
|
2021 Journal Article Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosisIoannides, Zara A., Csurhes, Peter A., Swayne, Andrew, Foubert, Philippe, Aftab, Blake T. and Pender, Michael P. (2021). Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis. Multiple Sclerosis Journal Experimental, Translational and Clinical, 7 (2), 1-12. doi: 10.1177/20552173211019772 |
|
2020 Journal Article Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisPender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2020). Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI insight, 5 (20) e144624. doi: 10.1172/jci.insight.144624 |
|
2018 Journal Article Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisPender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714 |
|
2017 Journal Article Defective T-cell control of Epstein-Barr virus infection in multiple sclerosisPender, Michael P., Csurhes, Peter A., Burrows, Jacqueline M. and Burrows, Scott R. (2017). Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clinical and Translational Immunology, 6 (1) e126, 1-17. doi: 10.1038/cti.2016.87 |
|
2017 Conference Publication Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosisPender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications. |
|
2017 Conference Publication Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialPender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2015 Journal Article Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcomeChan, Adeline, Yan, Jun, Csurhes, Peter, Greer, Judith and McCombe, Pamela (2015). Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome. Journal of Neuroimmunology, 286, 42-47. doi: 10.1016/j.jneuroim.2015.06.013 |
|
2015 Journal Article The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells inBlum, Stefan, Csurhes, Peter and McCombe, Pamela (2015). The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in. Journal of Neuroimmunology, 285, 53-56. doi: 10.1016/j.jneuroim.2015.05.017 |
|
2015 Conference Publication Impaired T cell control of Epstein-Barr virus infection in multiple sclerosisPender, Michael, Csurhes, Peter and Burrows, Scott (2015). Impaired T cell control of Epstein-Barr virus infection in multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, EC1Y 1SP United Kingdom: SAGE PUBLICATIONS LTD. doi: 10.1177/1352458515616527 |
|
2014 Journal Article Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosisPender, Michael P., Csurhes, Peter A., Smith, Corey, Beagley, Leone, Hooper, Kaye D., Raj, Meenakshi, Coulthard, Alan, Burrows, Scott R. and Khanna, Rajiv (2014). Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Multiple Sclerosis Journal, 20 (11), 1541-1544. doi: 10.1177/1352458514521888 |
|
2014 Journal Article Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré SyndromeBlum, Stefan, Csurhes, Peter, Reddel, Stephen, Spies, Judy and McCombe, Pamela (2014). Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome. Journal of Neuroimmunology, 267 (1-2), 92-96. doi: 10.1016/j.jneuroim.2013.12.007 |
|
2014 Journal Article Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosisPender, Michael P., Csurhes, Peter A., Pfluger, Casey M. M. and Burrows, Scott R. (2014). Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis. Multiple Sclerosis Journal, 20 (14), 1825-1832. doi: 10.1177/1352458514536252 |
|
2014 Conference Publication Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndromeBlum, Stefan, Csurhes, Peter, Reddel, Stephen, Spies, Judy and McCombe, Pamela (2014). Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndrome. ANZAN Annual Scientific Meeting 2014, Adelaide, South Australia, Australia, May 2014. Elsevier. doi: 10.1016/j.jocn.2014.06.032 |
|
2013 Conference Publication Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapyPender, M. P., Csurhes, P. A., Smith, C., Beagley, L., Hooper, K. D., Raj, M., Coulthard, A., Burrows, S. R. and Khanna, R. (2013). Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapy. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen Denmark, 2 - 5 October 2013. London, United Kingdom: Sage Publications Ltd.. doi: 10.1177/1352458513502429 |
|
2012 Journal Article CD8(+) T cells far predominate over CD4(+) T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell linesPender, Michael P., Csurhes, Peter A., Pfluger, Casey M. M. and Burrows, Scott R. (2012). CD8(+) T cells far predominate over CD4(+) T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines. Blood, 120 (25), 5085-5087. doi: 10.1182/blood-2012-06-437285 |
|
2012 Journal Article CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosisPender, Michael P., Csurhes, Peter A., Pfluger, Casey M.M. and Burrows, Scott R. (2012). CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 83 (3), 353-354. doi: 10.1136/jnnp-2011-300213 |
|
2012 Journal Article Interleukin-6 Gene Promoter-572 C Allele may play a role in rate of disease progression in Multiple SclerosisYan, Jun, Liu, Jia, Lin, Clement Yihao, Australia and New Zealand Multiple Sclerorsis Genetics Consortium, Csurhes, Peter A., Pender, Michael P., McCombe, Pamela A. and Greer, Judith M. (2012). Interleukin-6 Gene Promoter-572 C Allele may play a role in rate of disease progression in Multiple Sclerosis. International Journal of Molecular Sciences, 13 (10), 13667-13679. doi: 10.3390/ijms131013667 |
|
2011 Conference Publication CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosisPender, M. P., Csurhes, P. A., Pfluger, C. M. M. and Burrows, S. R. (2011). CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2011 Journal Article Decreased CD8(+) T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytesPender, Michael P., Csurhes, Peter A ., Pfluger, Casey M. M. and Burrows, Scott R. (2011). Decreased CD8(+) T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes. BMC Neurology, 11 (1) 95, 95-1-95-6. doi: 10.1186/1471-2377-11-95 |
